anemia%20-%20iron-deficiency
ANEMIA - IRON-DEFICIENCY
Anemia is a condition wherein the blood has low levels of red blood cells (RBC), hemoglobin (oxygen-carrying pigment in whole blood) and/or hematocrit (intact RBC in blood) making it insufficient to address the physiologic needs of the body.
Iron-deficiency anemia is the anemia that resulted from inadequate iron supplementation or excessive blood loss.
It is the most common nutritional disorder worldwide and accounts for more than half of anemia cases.
It is prevalent among preschool children and pregnant women.

Definition

  • A condition wherein the blood has low levels of red blood cells (RBC), hemoglobin (oxygen-carrying pigment in whole blood) or hematocrit (intact RBC in the blood) making it insufficient to address the physiologic needs of the body
  • Based on WHO, anemia is having hemoglobin concentration:
    • Men (>15 years old): <13 g/dL
    • Women (non-pregnant, >15 years old): <12 g/dL
    • Women (pregnant): <11 g/dL (declines to 0.5 g/dL in the 2nd trimester of pregnancy)
    • Children (12-14 years old): <12 g/dL
    • Children (5-11 years old): <11.5 g/dL
    • Children (6 months - 4 years old): <11 g/dL

Etiology

Causes of Anemia

  • Normocytic anemia when RBC morphology is unremarkable 
    • Blood loss - most common cause
    • Decreased RBC production due to low RBC production or destruction of precursors of RBC within the bone marrow, eg chronic disease
    • Increased RBC destruction, eg hemolysis
  • Macrocytic anemia wherein the RBC is larger than the nucleus of a small lymphocyte on a peripheral smear due to:
    • Megaloblastic causes: Folate and vitamin B12 deficiency, HIV infection, rare inborn errors of metabolism, myelodysplastic syndrome or congenital dyserythropoietic anemia
    • Nonmegaloblastic causes: Marked reticulocytosis, aplastic anemia, abnormal nucleic acid metabolism of erythroid precursors interfering with nucleic acid synthesis, abnormal RBC maturation, other causes such as Down syndrome, alcohol abuse, liver disease and hypothyroidism
  • Microcytic anemia when RBCs appear smaller due to the following pathologic processes:
    • Reduced iron availability/iron-deficiency anemia
    • Acquired disorders of heme synthesis, eg thalassemia 
    • Reduced globin production
    • Rare congenital disorders including sideroblastic anemias, porphyria, and defects of iron absorption transport, utilization and recycling
    • Inflammation or chronic disease
    • Lead poisoning

Signs and Symptoms

  • Primary symptoms include: Dyspnea (exertional or at rest), fatigue, palpitations, headache, faintness or lightheadedness, tinnitus, anorexia, gastrointestinal (GI) disturbances, loss of libido
  • Symptoms of severe anemia include: Lethargy, confusion, tachycardia, retinal hemorrhage that may lead to life-threatening complications such as congestive heart failure, angina, arrhythmia and/or myocardial infarction
  • Symptoms can be due to decreased oxygen delivery to tissues and in patients with acute and marked bleeding, the added insult of hypovolemia
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
3 years ago

Over the past few decades, there has been widespread concern about the increasing proportion of births born by caesarean delivery. The rising rate of primary caesarean section has led to the increased number of obstetric population with a history of prior caesarean delivery. Although this group of women may be offered planned vaginal birth after previous caesarean section (VBAC) or elective repeat caesarean section (ERCS), the VBAC rate is generally low particularly in well-developed countries. In the United States, the VBAC rate has decreased to 8.5% by 2006, while the total caesarean rate has increased to 31.1%.1

one year ago
Kidney and bladder stones (urinary tract stones) are not risk factors for osteoporosis in postmenopausal women, according to the women’s health initiative.
Lianne Cowie, 3 years ago

Tumor necrosis factor (TNF)-α inhibitors are commonly used in the treatment of inflammatory bowel disease (IBD), but the effects of these agents on pregnancy outcomes remain unclear. Now, a systematic review of the English literature has indicated that they pose little risk to the mother or her infant, even if use is continued through the third trimester.

Pank Jit Sin, 3 years ago

Urinary incontinence is often mistakenly associated with immaturity or impaired mental capacity. Thus, women who suffer from urinary leakage often face embarrassment and a compromised quality of life.